Successful treatment of refractory adult-onset Still's disease with anti-CD20 monoclonal antibody.
Bartoloni
E
E
Alunno
A
A
Luccioli
F
F
Santoboni
G
G
Gerli
R
R
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D016706:Still's Disease, Adult-Onset / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab